Your browser doesn't support javascript.
loading
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.
Hong, Lingzhi; Aminu, Muhammad; Li, Shenduo; Lu, Xuetao; Petranovic, Milena; Saad, Maliazurina B; Chen, Pingjun; Qin, Kang; Varghese, Susan; Rinsurongkawong, Waree; Rinsurongkawong, Vadeerat; Spelman, Amy; Elamin, Yasir Y; Negrao, Marcelo V; Skoulidis, Ferdinandos; Gay, Carl M; Cascone, Tina; Gandhi, Saumil J; Lin, Steven H; Lee, Percy P; Carter, Brett W; Wu, Carol C; Antonoff, Mara B; Sepesi, Boris; Lewis, Jeff; Gibbons, Don L; Vaporciyan, Ara A; Le, Xiuning; Jack Lee, J; Roy-Chowdhuri, Sinchita; Routbort, Mark J; Gainor, Justin F; Heymach, John V; Lou, Yanyan; Wu, Jia; Zhang, Jianjun; Vokes, Natalie I.
Affiliation
  • Hong L; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Aminu M; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Li S; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lu X; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.
  • Petranovic M; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Saad MB; Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.
  • Chen P; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Qin K; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Varghese S; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rinsurongkawong W; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rinsurongkawong V; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Spelman A; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Elamin YY; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Negrao MV; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Skoulidis F; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gay CM; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Cascone T; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gandhi SJ; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lin SH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lee PP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Carter BW; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wu CC; Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Antonoff MB; Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sepesi B; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lewis J; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gibbons DL; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Vaporciyan AA; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Le X; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jack Lee J; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Roy-Chowdhuri S; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Routbort MJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gainor JF; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Heymach JV; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Lou Y; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wu J; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.
  • Zhang J; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Vokes NI; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nat Commun ; 14(1): 695, 2023 02 08.
Article in En | MEDLINE | ID: mdl-36755027

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2023 Document type: Article Affiliation country: Country of publication: